The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.
Prevention Matters: Time for Global Action and Effective Implementation
Abstract
During the last few years, dementia prevention based on modifiable lifestyle factors has gained increasing attention. Cohort studies with follow-ups extending up to decades have identified several risk and protective factors, and very recently new randomized controlled trials with multidomain approach have provided promising evidence by showing that modifying simultaneously several risk factors, it is possible to maintain and improve cognitive capacity among older at-risk persons. Several lifestyle-based multidomain trials are under preparation or ongoing and to facilitate international collaboration and effective worldwide dementia prevention, the World Wide FINGERS interdisciplinary network (http://wwfingers.com) was recently initiated. Additionally, several new implementation projects are taking the first steps from trial setting to real-life implementation of a dementia prevention program. This paper highlights the recent perspectives from the field of Alzheimer's disease and reflects the implications and importance of current achievements. Finally, predictions for the future work especially in terms of global collaboration and implementation will be discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The success of FINGER has led to the launch of multidomain intervention studies in other countries, including the Alzheimer's Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER).142”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [142]
In the citing paper
“The lifestyle factors underpinning cognitive reserve are potentially amenable to change and hence may provide a basis for preventative intervention [21, 22].”
From Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis (2019) · cites this paper as [22]
Citations
Cites
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689
Self-citationPotential for primary prevention of Alzheimer's disease: an analysis of population-based data
Norton, S., Matthews, F. E., Barnes, D. E., Yaffe, K., & Brayne, C. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70136-x · Cited by 2,466 · cited 1×
“Lifestyle matters, since it has been estimated that about one third of AD cases could be attributable to modifi-able risk factors [2, 3].”
Kivipelto, M., Ngandu, T., Laatikainen, T., Winblad, B., Soininen, H., & Tuomilehto, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70537-3 · Cited by 1,126
Self-citationLeisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease
Rovio, S., Kåreholt, I., Helkala, E.-L., Viitanen, M., Winblad, B., Tuomilehto, J., Soininen, H., Nissinen, A., & Kivipelto, M. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70198-8 · Cited by 1,054 · cited 1×
“The CAIDE study linked midlife cardiovascular risk factors such as high blood pressure and cholesterol [4], smoking [5], physical inactivity [6, 7], alcohol consumption [8], poor diet [9, 10], and psychosocial factors [11–13] to increased risk of dementia and AD later in life.”
Self-citationIncidence of dementia over three decades in the Framingham heart study
Satizabal, C. L., Beiser, A. S., Chouraki, V., Chêne, G., Dufouil, C., & Seshadri, S. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504327 · Cited by 1,051 · cited 1×
“Lately, some studies have indeed indicated that age-adjusted prevalence of dementia has been decreasing and the main hypothesis behind the change is that the lifestyle has been improved [22–24].”
Kivipelto, M., Solomon, A., Ahtiluoto, S., Ngandu, T., Lehtisalo, J., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.09.012 · Cited by 589
Self-citationHeavy Smoking in Midlife and Long-term Risk of Alzheimer Disease and Vascular Dementia
Rusanen, M., Kivipelto, M., Quesenberry, C. P., Zhou, J., & Whitmer, R. A. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.393 · Cited by 329
Self-citationHakansson, K., Rovio, S., Helkala, E.-L., Vilska, A.-R., Winblad, B., Soininen, H., Nissinen, A., Mohammed, A. H., & Kivipelto, M. (2009) · BMJ · doi:10.1136/bmj.b2462 · Cited by 328
Self-citationAnttila, T., Helkala, E.-L., Viitanen, M., Kåreholt, I., Fratiglioni, L., Winblad, B., Soininen, H., Tuomilehto, J., Nissinen, A., & Kivipelto, M. (2004) · BMJ · doi:10.1136/bmj.38181.418958.be · Cited by 323
Self-citation
Cited by
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
2021 Alzheimer's disease facts and figures
(2021) · Alzheimer's & Dementia · doi:10.1002/alz.12328 · Cited by 2,201
Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease
Kivipelto, M., Mangialasche, F., & Ngandu, T. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0070-3 · Cited by 1,173
Self-citationSocial Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis
Evans, I. E. M., Martyr, A., Collins, R., Brayne, C., & Clare, L. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180501 · Cited by 531
“As these lifestyle factors are modifiable, interventions aimed at reducing risk and enhancing modifiable protective factors may provide a basis to ameliorate poor cognitive function [21, 22].”
BackgroundSolomon, A., Stephen, R., Altomare, D., Carrera, E., Frisoni, G. B., Kulmala, J., Molinuevo, J. L., Nilsson, P. M., Ngandu, T., Ribaldi, F., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00875-8 · Cited by 96
“However, several characteristics specific for the FINGER intervention model have been emphasized as potential reasons behind its cognitive benefits [25]: (i) selection of an at-risk older population (60–77 years) based on the validated Cardiovascular Risk Factors, Aging and Dementia (CAIDE) Risk Score [26]; (ii) multi…”
MethodSelf-citationCattaneo, G., Bartrés‐Faz, D., Morris, T. P., Sánchez, J. S., Macià, D., Tarrero, C., Tormos, J. M., & Pascual‐Leone, Á. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00321 · Cited by 90
Innes, K. E., & Sambamoorthi, U. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200960 · Cited by 92
“With effective diseasemodifying treatments for cognitive impairment (CI) or ADRD still lacking after decades of disappointing clinical trials, research is shifting increasingly to prevention and early intervention [6, 7], with large-scale risk reduction trials now underway in multiple countries [7–11], including the U.”
Kulmala, J., Rosenberg, A., Ngandu, T., Hemiö, K., Tenkula, T., Hyytiä, A., Vienola, M., Huhtamäki-Kuoppala, M., Saarinen, A., Korkki, S., et al. (2021) · European Journal of Public Health · doi:10.1093/eurpub/ckab087 · Cited by 47
Self-citationInnes, K. E., & Sambamoorthi, U. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191311 · Cited by 49
“With effective treatments for cognitive impairment or ADRD still lacking after decades of clinical trials and billions of dollars invested, research is shifting increasingly to prevention and early intervention [6, 7], with large-scale risk reduction trials now underway in multiple countries [7–11], including the U.”
Multidomain Lifestyle Intervention Strategies for the Delay of Cognitive Impairment in Healthy Aging
Toman, J., Klímová, B., & Vališ, M. (2018) · Nutrients · doi:10.3390/nu10101560 · Cited by 50
Zülke, A. E., Luppa, M., Köhler, S., & Riedel-Heller, S. G. (2022) · PLOS ONE · doi:10.1371/journal.pone.0277037 · Cited by 34
“Current evidence suggests that the optimal window of opportunity for primary prevention of dementia is between 60 and 77 years [30,31].”
BackgroundObesity in Late-Life as a Protective Factor Against Dementia and Dementia-Related Mortality
Natale, G., Zhang, Y., Hanes, D. W., & Clouston, S. (2023) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175221111658 · Cited by 39
“In previous studies, cardiovascular factors, such as myocardial infarction, transient ischemic attacks, stroke history, smoking, and hypertension, seem unrelated to weight loss and dementia.”
BackgroundRosenberg, A., Untersteiner, H., Guazzarini, A. G., Bödenler, M., Bruinsma, J., Buchgraber-Schnalzer, B., Colombo, M., Crutzen, R., Diaz, A., Fotiadis, D. I., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01615-4 · Cited by 32
Self-citationTainta, M., Ecay‐Torres, M., de Arriba, M., Barandiarán, M., Otaegui-Arrazola, A., Iriondo, A., García‐Sebastián, M., Estanga, A., Saldias, J., Clerigué, M., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01393-z · Cited by 26
“FINGER results hold the promise that healthy eating, exercise, and cognitive and social activities may have favorable effects on cognition, functional independence [42, 43], and health-related quality of life [34] and reduce the need for health care services [44] in older adults.”
BackgroundSelf-citationInsulin Peptides as Mediators of the Impact of Life Style in Alzheimer’s disease
Fernandez, A. M., Santi, A., & Aleman, I. T. (2018) · Brain Plasticity · doi:10.3233/bpl-180071 · Cited by 27
Bruinsma, J., Visser, L. N. C., Abaci, A., Rosenberg, A., Diaz, A., Hanke, S., Crutzen, R., Mangialasche, F., Kivipelto, M., & Thunborg, C. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1386688 · Cited by 14
“Moreover, 80% of the participants enjoyed meeting others involved in the intervention (44).”
BackgroundSelf-citationMeernik, C., Eilat-Adar, S., Leonard, D., Barlow, C. E., Gerber, Y., Tesler, R., Shanks, C. B., Gabriel, K. P., Pavlovic, A., DeFina, L. F., et al. (2024) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-024-01663-x · Cited by 8
“Additionally, given the complexity of the brain changes that occur with dementia [1] and its multifactorial risk factors [30, 62], single lifestyle behaviors may not confer similar neuroprotective effects for all individuals.”
Background“Guttmann Cognitest”®, preliminary validation of a digital solution to test cognitive performance
Cattaneo, G., Pachón‐García, C., Roca‐Ventura, A., Alviarez‐Schulze, V., Opisso, E., García‐Molina, A., Bartrés‐Faz, D., Pascual‐Leone, Á., Tormos, J. M., & Sánchez, J. S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.987891 · Cited by 11
“…years, an increasing number of studies have tried to find effective strategies to prevent the development of cognitive impairment, dementia, and functional impairment due to Alzheimer’s disease and other brain-related pathologies (Amariglio et al., 2015; Cattaneo et al., 2018; Kulmala et al., 2018).”
BackgroundA call for a global ‘bigger’ data approach to Alzheimer disease
Perakslis, E. D., Riordan, H., Friedhoff, L. T., Nabulsi, A. A., & Pich, E. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.86 · Cited by 9
Etholén, A., Kouvonen, A. M., Hänninen, M., Kulmala, J., Rahkonen, O., Mänty, M., & Lallukka, T. M. (2023) · Preventive Medicine · doi:10.1016/j.ypmed.2023.107830 · Cited by 9
Self-citationWerner, P., & AboJabel, H. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200780 · Cited by 5
“Moreover, since the main priority is to move toward the implementation of these recommendations at an individual level [19, 20], the aim of this study was to examine perceptions about and engagement in behav-iorsaimedatreducingtheriskofdevelopingdementiaamongtheadultpopulationinIsrael.”
Meernik, C., Eilat-Adar, S., Leonard, D., Barlow, C. E., Gerber, Y., Tesler, R., Shanks, C. B., Gabriel, K. K. P., Pavlovic, A., DeFina, L. F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27124001
Meernik, C., Eilat-Adar, S., Leonard, D., Barlow, C. E., Gerber, Y., Tesler, R., Shanks, C. B., Gabriel, K. K. P., Pavlovic, A., DeFina, L. F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27123998
Metadata
- Authors
- Kulmala, J., Ngandu, T., & Kivipelto, M.
- Affiliations
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- Corresponding author
- Kulmala, Jenni
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2018-06-12
- Volume
- 64
- Issue
- s1
- Pages
- S191-S198
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2789534561
- Cited by
- 26
- References
- 24
- Citations by year
- 2024: 6 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 1 · 2018: 6
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- WOS
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Cognitive Abilities and Testing
- Keywords
- dementia prevention, modifiable lifestyle factors
- MeSH terms
- Clinical Trials as Topic, Dementia, Humans, Risk Reduction Behavior, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.